Guidance and quality standards Awaiting development
Showing 1 to 3 of 3
Title | Type |
---|---|
Dupilumab for treating moderate to severe chronic obstructive pulmonary disease [ID6235] | Technology appraisal guidance |
Mepolizumab for treating chronic obstructive pulmonary disease [ID1237] | Technology appraisal guidance |
Virtual Wards for COPD exacerbations | Medical technologies guidance |